Here are some drugs used for treating Acute Lymphoblastic Leukemia (ALL) based on the knowledge base:
Chemotherapy Drugs:
- Adriamycin (doxorubicin)
- Cerubidine (daunorubicin)
- Neosar (cyclophosphamide)
- Trexall (methotrexate)
- Vincasar (vincristine)
- Elspar (asparaginase)
- Cytosar-U (cytarabine)
Targeted Therapy Show Full Answer
Here are some drugs used for treating Acute Lymphoblastic Leukemia (ALL) based on the knowledge base:
Chemotherapy Drugs:
- Adriamycin (doxorubicin)
- Cerubidine (daunorubicin)
- Neosar (cyclophosphamide)
- Trexall (methotrexate)
- Vincasar (vincristine)
- Elspar (asparaginase)
- Cytosar-U (cytarabine)
Targeted Therapy Drugs:
- Rituxan (rituximab): Blocks CD20 protein on B cells.
- Blincyto (blinatumomab): Used for refractory or relapsed B-cell ALL.
- Besponsa (inotuzumab ozogamicin): Used for refractory or relapsed B-cell ALL.
- Gleevec (imatinib): For Philadelphia chromosome-positive ALL.
- Sprycel (dasatinib): For Philadelphia chromosome-positive ALL.
- Tasigna (nilotinib): For Philadelphia chromosome-positive ALL.
- Iclusig (ponatinib): For Philadelphia chromosome-positive ALL.
- Arranon (nelarabine): For refractory or relapsed T-cell ALL.
Steroids:
- Decadron (dexamethasone)
- Deltasone (prednisone)
Newer Drugs:
- Clolar (clofarabine): Approved for childhood ALL, showing promise in adults.
- Oncaspar (pegaspargase): A form of asparaginase.
Additional Notes:
- Chemotherapy: Often given in cycles, which include doses of medication followed by rest periods.
- Stem Cell Transplant: Sometimes used in conjunction with chemotherapy.
These treatments can vary based on the specific subtype of ALL and the individual patient's response to therapy.
July 10, 2024
Join
Your Privacy Choices
